---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021274"
form_type: "8-K"
ticker: "CELC"
cik: "0001603454"
company_name: "Celcuity Inc."
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:42:05.451047+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Celcuity launches $150M convertible notes + $75M common stock offerings; also to draw $30M loan

## Summary
- Concurrent underwritten offerings: $150M convertible notes due 2031 and $75M common stock; 30-day over-allotment options for additional $22.5M notes and $11.25M stock.
- Proceeds to fund capped call transactions (reduce dilution on note conversion) and for working capital, clinical trials, R&D.
- Intends to draw $30M Term D Loan in late August 2025 after achieving clinical milestone under existing loan agreement.
- Amended loan with Innovatus/Oxford: $25k fee, extended conversion right on Term A loan to $10/share through May 9, 2026.
- Preliminary cash at June 30, 2025: ~$168.4M (down from $283.1M a year ago).

## SEC filing metadata
- accession: 0001641172-25-021274
- form_type: 8-K
- ticker: CELC
- cik: 0001603454
- company_name: Celcuity Inc.
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603454/000164117225021274/0001641172-25-021274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603454/000164117225021274/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021274
- JSON: https://secwatch.observer/filing/0001641172-25-021274.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021274.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.